Pfizer Advertising Blunder for the Ages
Here is a blunder for the history books, or perhaps a case study for a business school. With just one racy advertisement, Pfizer has taken a venerable product that has been widely used by who-knows-how-many millions of people for more than 100 years and damaged its reputation by alienating a huge swath of the consumer-buying […]
Read More »Category : News
Celesio’s new CEO unveils radical shakeup
Celesio may sell Manufacturer Solutions division Celesio’s new Chief Executive Markus Pinger announced a radical shakeup of the drugs distributor, two months after taking the helm amid sliding earnings and discord with its biggest shareholder. Celesio said on Wednesday it may sell its Manufacturer Solutions division to focus on distribution, would slash costs to improve […]
Read More »Category : News
Amgen Takes $780M Charge For Marketing Probes
In an effort to rid itself of several nagging civil and criminal investigations, as well as several whistleblower lawsuits, Amgen has reached an agreement to settle charges that certain sales and marketing pratices were illegal. As part of the move, the biotech is taking a $780 million in its third quarter, although talks are still […]
Read More »Category : News
Pfizer sued over drug recall
The animal health wing of the US pharmaceutical giant Pfizer is being sued by a Chinese specialty veterinary medicine manufacturer after the company stopped selling its 3-Nitro anti-coccidial product in June following concerns over arsenic residues in meat. Zhejiang Rongyao Chemical is claiming a breach of contract as the Chinese company had an exclusive multi-year […]
Read More »Category : News
Novartis To Eliminate Another 2,000 Jobs
n a bid to grapple with its pipeline and pricing pressures, Novartis is going to cut 1,100 from Switzerland, where its operations are headquartered, and another 900 jobs from the US. The move extends a round of layoffs that began a year ago with the elimination of 1,400 US sales reps and another 550 jobs […]
Read More »Category : News
Shocking! Lilly Pulls Xigris Drug After Study Fails
In the latest setback for Eli Lilly, the drugmaker is withdrawing its 10-year-old Xigris treatment for septic shock after a study found the medication failed to help patients live longer in a clinical trial. Specifically, the study did not find a statistically significant reduction in 28-day all-cause mortality in patients with septic shock. The study, […]
Read More »Category : News
FDA Updates Warnings on Methylene Blue, Linezolid, and Serotonergics
FDA has fine-tuned a warning issued in July to avoid prescribing either methylene blue or linezolid (Zyvox, Pfizer) in combination with serotonergic agents because of the potential to cause serotonin syndrome. Today, the FDA announced that the risk for this harmful interaction appears to be confined, in general, to 2 specific types of serotonergic drugs: […]
Read More »Category : News
Actavis Opiate Shipment Hit By US Cargo Thieves
Generic drugmaker Actavis suffered a full truckload (FTL) cargo theft on October 19, losing more than 30 pallets of opioid analgesics, benzodiazepines and epilepsy drugs. The thieves made off with 14 pallets of oxycodone HCl tablets (around 70,000 units), six pallets of anxiety drug alprazolam (around 24,000 units) and nine pallets of the epilepsy drug […]
Read More »Category : News
France Tightens Conflict Of Interest Rules
As promised, the French National Assembly recently passed a law that imposes fines of up to $40,000 on scientists who advise the government on pharmaceutical coverage decisions, but fail to disclose any conflicts of interest. However, the Senate must still vote and a reading is expected next week, according to Nature. The move follows a […]
Read More »Category : News
EU Probes J&J And Novartis Over Generic Deals
The European Union is investigating agreements between Johnson & Johnson and Novartis to determine whether they illegally conspired to delay the entry of a generic version of the Fentanyl painkiller from entering the Netherlands. If the drugmakers had ‘contractual arrangements’ that hindered a generic, this could breach EU antitrust rules. The probe is only the […]
Read More »Category : News
